$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224032907 Filed on August 19, 2024

Income Statement

Concept	2024 Q2
Revenue	$742.1K
YoY Change	52.83%
Cost Of Revenue	$418.7K
YoY Change	41815.72%
Gross Profit	$323.4K
YoY Change	-33.27%
Gross Profit Margin	43.57%
Selling, General & Admin	$386.6K
YoY Change	-46.89%
% of Gross Profit	119.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.72K
YoY Change	-13.53%
% of Gross Profit	7.95%
Operating Expenses	$386.6K
YoY Change	-46.89%
Operating Profit	-$63.20K
YoY Change	-74.01%
Interest Expense	$156.9K
YoY Change	-63.63%
% of Operating Profit
Other Income/Expense, Net	$156.9K
YoY Change	-215.81%
Pretax Income	$93.70K
YoY Change	-124.75%
Income Tax
% Of Pretax Income
Net Earnings	$93.70K
YoY Change	-124.74%
Net Earnings / Revenue	12.63%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00
COMMON SHARES
Basic Shares Outstanding	86.06M shares
Diluted Shares Outstanding	81.38M shares

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.00K
YoY Change	1.84%
Cash & Equivalents	$53.00K
Short-Term Investments
Other Short-Term Assets	$25.22K
YoY Change	185.29%
Inventory
Prepaid Expenses
Receivables	$1.408M
Other Receivables	$0.00
Total Short-Term Assets	$1.486M
YoY Change	-14.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.830M
YoY Change	-43.46%
Goodwill	$11.12M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$344.3K
YoY Change	592.58%
Total Long-Term Assets	$29.07M
YoY Change	784.44%
TOTAL ASSETS
Total Short-Term Assets	$1.486M
Total Long-Term Assets	$29.07M
Total Assets	$30.56M
YoY Change	508.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.295M
YoY Change	29.58%
Accrued Expenses	$1.360M
YoY Change	61.02%
Deferred Revenue	$142.9K
YoY Change	53.06%
Short-Term Debt	$545.3K
YoY Change	-94.29%
Long-Term Debt Due	$2.695M
YoY Change	42.6%
Total Short-Term Liabilities	$15.11M
YoY Change	-53.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.11M
Total Long-Term Liabilities	$0.00
Total Liabilities	$15.11M
YoY Change	-53.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.45M
YoY Change	-15.95%
Common Stock	$86.76K
YoY Change	33.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$14.85M
YoY Change
Total Liabilities & Shareholders Equity	$30.56M
YoY Change	508.46%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	$93.70K
YoY Change	-124.74%
Depreciation, Depletion And Amortization	$25.72K
YoY Change	-13.53%
Cash From Operating Activities	$88.58K
YoY Change	-127.22%
INVESTING ACTIVITIES
Capital Expenditures	$243.3K
YoY Change	588.56%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$243.3K
YoY Change	588.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.84K
YoY Change	-66.81%
NET CHANGE
Cash From Operating Activities	88.58K
Cash From Investing Activities	-243.3K
Cash From Financing Activities	70.84K
Net Change In Cash	-83.85K
YoY Change	-43.1%
FREE CASH FLOW
Cash From Operating Activities	$88.58K
Capital Expenditures	$243.3K
Free Cash Flow	-$154.7K
YoY Change	-57.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	386552	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	727772	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	295901	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	229814	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
	dei	City Area Code CityAreaCode	(877)
	dei	Local Phone Number LocalPhoneNumber	661-4811
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88909195	shares
CY2024Q2	us-gaap	Cash Cash	53002	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1408209	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25215	usd
CY2024Q2	us-gaap	Land Land	15776526	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2677	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	344286	usd
CY2024Q2	us-gaap	Goodwill Goodwill	11118187	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142933	usd
CY2024Q2	us-gaap	Deposits Deposits	20500	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	269593	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	519631	usd
CY2024Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7563322	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	15105445	usd
CY2024Q2	us-gaap	Liabilities Liabilities	15105445	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	603500	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	86759	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38513496	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23450890	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14849502	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30558446	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
CY2024Q2	us-gaap	Deferred Income Current DeferredIncomeCurrent		usd
CY2024Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	ILAL	Common Stock Payable CommonStockPayable		usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2024Q1	ILAL	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised		usd
CY2023Q2	ILAL	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt		usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	ILAL	Dividend On Series B DividendOnSeriesB		usd
	ILAL	Series A Shares Issued For Conversion Of Related Party Notes Payable SeriesASharesIssuedForConversionOfRelatedPartyNotesPayable		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes		usd
	ILAL	Noncash Settlement Of Derivative Liability NoncashSettlementOfDerivativeLiability		usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23450890	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2024Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56111
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2023Q4	us-gaap	Cash Cash	140247	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1652086	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16815	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1486426	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1809148	usd
CY2023Q4	us-gaap	Land Land	15551526	usd
CY2024Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1830344	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1818825	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2677	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53468	usd
CY2023Q4	us-gaap	Goodwill Goodwill	11118187	usd
CY2024Q2	us-gaap	Assets Assets	30558446	usd
CY2023Q4	us-gaap	Assets Assets	30353831	usd
CY2023Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	4521222	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1359705	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1756937	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	93382	usd
CY2023Q4	us-gaap	Deposits Deposits	20500	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	781924	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	652077	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	8900000	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7358600	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28656801	usd
CY2023Q4	us-gaap	Liabilities Liabilities	28656801	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	603500	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86759195	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83759195	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79658165	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76658165	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	79658	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28476622	usd
CY2023Q4	ILAL	Common Stock Payable CommonStockPayable	31939	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3000000	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27194738	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1093530	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30353831	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	742095	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	485580	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	418738	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	999	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	323357	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	484581	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	169288	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28175	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	217264	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	699597	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-63195	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-243191	usd
CY2024Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	252562	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-101777	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	95670	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	431369	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	675999	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1014916	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	156892	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-135468	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-446185	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1166022	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	93697	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
	us-gaap	Net Income Loss NetIncomeLoss	3743848	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2287221	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	114308	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	60003	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	114308	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	75003	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20612	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-438663	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3629540	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2302221	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81384695	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81384695	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61929046	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61929046	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81133428	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81133428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63973603	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63973603	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1093530	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3026	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100919	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	49126	usd
CY2024Q1	ILAL	Stock Issued During Period Value Conversion Of Related Party Debt StockIssuedDuringPeriodValueConversionOfRelatedPartyDebt	9456250	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3650150	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	14431048	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	22630	usd
CY2024Q2	ILAL	Stock Issued During Period Value Pursuant To Inducement Agreement StockIssuedDuringPeriodValuePursuantToInducementAgreement	12500	usd
CY2024Q2	ILAL	Adjustments To Additional Paid In Capital Series A Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalSeriesADividendsInExcessOfRetainedEarnings	-91678	usd
CY2024Q2	ILAL	Settlement Of Derivative Liability SettlementOfDerivativeLiability	282517	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	93697	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14849502	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1800000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	2674976	usd
CY2023Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	25354972	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	147805	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18504	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q2	ILAL	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	3100	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	60003	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	60003	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-28049295	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-28049295	usd
	us-gaap	Net Income Loss NetIncomeLoss	3743848	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2287221	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	365035	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	174598	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	15000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49329	usd
	us-gaap	Depreciation Depreciation	77253	usd
	us-gaap	Depreciation Depreciation	59494	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	203607	usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	36062	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	229814	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-101777	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-243876	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51666	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8400	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40363	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	101450	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7138	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	502575	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	694	usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	154462	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4521222	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	281746	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	159018	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	498803	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	49551	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	92595	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	280270	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-288488	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	321919	usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	225000	usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	250596	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	278141	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	179700	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-503141	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108377	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	250000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	91678	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	228190	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	55000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	91513	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	132446	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	204722	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	25052	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	135028	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	344180	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	135626	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399529	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-87245	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2664	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	140247	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49374	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53002	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	52038	usd
	us-gaap	Interest Paid Net InterestPaidNet	29782	usd
	us-gaap	Interest Paid Net InterestPaidNet	47285	usd
	ILAL	Dividend On Series B DividendOnSeriesB	15000	usd
	ILAL	Dividend On Series C DividendOnSeriesC	22630	usd
	ILAL	Dividend On Series C DividendOnSeriesC	60003	usd
	ILAL	Series A Shares Issued For Conversion Of Related Party Notes Payable SeriesASharesIssuedForConversionOfRelatedPartyNotesPayable	9456250	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49126	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	104250	usd
	ILAL	Noncash Settlement Of Derivative Liability NoncashSettlementOfDerivativeLiability	282517	usd
	us-gaap	Stock Issued1 StockIssued1	164367	usd
	us-gaap	Stock Issued1 StockIssued1	15000	usd
CY2024Q2	ILAL	Working Capital WorkingCapital	13600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3700000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zsRkOcgGsYeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zZHnMsZ53469">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain numbers from 2023 have been reclassified to conform with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zW6lge5GtXg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zLRth3uULfA7">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived assets for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	269593	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	269593	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	781924	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	229814	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	282517	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	269593	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5830969	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	726512	usd
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	169288	usd
	us-gaap	Advertising Expense AdvertisingExpense	336977	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	28175	usd
	us-gaap	Advertising Expense AdvertisingExpense	288259	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44107500	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	42867500	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_z1ypWPDxTLd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zlY7miAS2a2c">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	844127	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	772596	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1830344	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1818825	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77253	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59494	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	250000	shares
CY2023	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	250000	shares
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	150000	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	150000	usd
	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	1500000	usd
CY2024Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	500000	usd
CY2024Q2	ILAL	Notes Payable Gross NotesPayableGross	2694762	usd
CY2023Q4	ILAL	Notes Payable Gross NotesPayableGross	2674762	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	2694762	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	2674762	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2694762	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2674762	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	545285	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	9585111	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	25654	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	33034	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	519631	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	9552077	usd
CY2024Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	519631	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9552077	usd
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2680000	usd
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	0	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1090617	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1516622	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1110022	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-926798	usd
CY2024Q2	ILAL	Net Budget NetBudget	1556000	usd
CY2023Q4	ILAL	Net Budget NetBudget	1556000	usd
CY2024Q2	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2023Q4	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2024Q2	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79658165	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76658165	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
	ILAL	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings Shares AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarningsShares	94827	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38107500	shares
CY2023Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
CY2023	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y2M1D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38107500	shares
CY2024Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P3Y8M1D
CY2024Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	38107500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M20D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6000000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd

Files In Submission

Name	View Source	Status
0001493152-24-032907-index-headers.html	Edgar Link	pending
0001493152-24-032907-index.html	Edgar Link	pending
0001493152-24-032907.txt	Edgar Link	pending
0001493152-24-032907-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20240630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ilal-20240630_cal.xml	Edgar Link	unprocessable
ilal-20240630_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
ilal-20240630_lab.xml	Edgar Link	unprocessable
ilal-20240630_pre.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2024 Q2 Form 10-Q Financial Statement

#000149315224032907 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2024 Q2 Form 10-Q Financial Statement

#000149315224032907 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal